Shoosmiths acts for M Squared Lasers in health research agreement

Shoosmiths has advised laser developer and manufacturer M Squared Lasers on an agreement to develop new technologies with the University of St Andrews.

M Squared Lasers develops and manufactures lasers and photonic instruments for industrial and scientific purposes.

The business has over twenty years of experience in R&D and manufacturing.

The patent licence agreement covers more than 100 patents, which researchers will use to develop commercial applications for the health sector.

The patents cover areas such as imaging and raman spectroscopic analysis which can be used in the fight against cancer by accurately distinguishing between normal and unhealthy cells and tissue.

Stuart Malcolm, partner in the IPCI Team, led the negotiations with the University of St Andrews assisted by Olly Leyden, IP solicitor.

Head of the business innovation unit at M Squared Lasers, Dr Nils Hemplar, said: “I would like to thank Shoosmiths for their expert advice throughout the agreement process, which has enabled us to match our knowledge with relevant academic research to lead significant developments in healthcare.

“We have a longstanding relationship with Stuart and his team and their specialist approach, coupled with a very evident passion for and definitive understanding of our technology sector, ensures that we are provided with distinctive and dynamic advice, always against the backdrop of an enlightened approach, determination and absolute commitment.”

Mr Malcolm, said: “It was a pleasure to guide M Squared Lasers through another strategic licence arrangement in its growing IP portfolio and one that could lead to an improved understanding of life limiting illnesses and conditions such as cancer and alzheimer’s disease.

“Our experience and expertise in intellectual property means we are well placed to help clients promote and accelerate their unique educational, research, intellectual and business assets.”